Status and phase
Conditions
Treatments
About
Part A of this trial will evaluate the safety and tolerability of a single unilateral administration of one of two dose levels of AAVAnc80-hOTOF and will evaluate the Akouos delivery device to safely achieve the intended product performance.
Full description
The following two dose levels will be tested sequentially:
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Criteria for Inclusion:
Criteria for Exclusion:
Primary purpose
Allocation
Interventional model
Masking
14 participants in 2 patient groups
Loading...
Central trial contact
Akouos Clinical Trials
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal